Good day,
I am writing to let you know that your $100 MarketBeat account credit is expiring in less than 12 hours. Over a hundred of your fellow MarketBeat subscribers have upgraded to MarketBeat All Access Pass in the last few days (and have gotten a great deal on their subscription). Unfortunately, you haven't taken action yet.
We are making the first month of MarketBeat All Access available for FREE for anyone that registers tonight by 11:59 PM Pacific Time. If you want to continue your subscription after your first month, you'll still receive the $100 discount on your first year's subscription ($149.00 instead of $249.00).
Make the Move - Upgrade to MarketBeat All Access for Free
Why Upgrade to MarketBeat All Access? - Access Award-Winning Research Tools - MarketBeat All Access offers a full suite of modern stock research and portfolio monitoring tools backed by comprehensive financial datasets that you can't get anywhere else. MarketBeat tracks more than two million market events and news stories each year, creating an unrivaled ability to provide accurate, complete, and up-to-the-minute financial information.
- Cut Through the Noise - Equities research analysts issue more than 175,000 distinct "Buy" and "Sell" recommendations each year. After tracking the ROI of following analyst recommendations for nearly a decade, we know which analysts you should pay attention to and which you can safely ignore. With your All Access subscription, you'll get access to our list of top-rated and most-accurate brokers as well as their most recent "Buy" and "Sell" recommendations.
- Real-Time Data for Timely Trades - You will be among the first to receive your daily newsletter and instant email and SMS alerts for important market events. You won't need to scour through dozens of different websites to find news relevant to your stocks. Use MarketBeat All Access to get ratings, earnings, dividends, insider trades, and headlines delivered to your inbox automatically, every day.
Save $100 on an All Access Pass Subscription (Ends Tonight!)
Matthew Paulson
Founder and CEO, MarketBeat
P.S. This offer is only available through 11:59 PM Pacific tonight. Take action now!
Register Here for MarketBeat All Access (Free for 30 Days!)
This Month's Exclusive Story Axon Got Caught in the SaaS Crash—Its Earnings Say That Was a MistakeReported by Leo Miller. Posted: 2/26/2026. 
Key Points - Axon shares surged after Q4 earnings, snapping a months-long selloff that had cut the stock roughly in half from its all-time high.
- The broader SaaS panic dragged Axon down alongside pure software names, but the company's hardware-integrated model may make that comparison a poor one.
- Analysts still see meaningful upside even after trimming their price targets post-report.
- Special Report: [Sponsorship-Ad-6-Format3]
After getting battered in the second half of 2025 and in early 2026, shares of defense company Axon Enterprise (NASDAQ: AXON) suddenly roared back. After reporting its Q4 financial results on Feb. 24, Axon shares jumped nearly 18% the following day. Axon hit an all-time closing high near $871 last August. Prior to the latest earnings report, the stock had fallen roughly 50% from that peak. While headlines focus on Tesla's car sales, tech analyst Jeff Brown says the real story is Tesla's role in a $25 trillion AI revolution — one that Nvidia's CEO himself has called a "multi-trillion-dollar future industry" — and he's uncovered a little-known stock 168 times smaller than Nvidia that could be positioned to ride this breakthrough. Click here now to see the full report Even after the recent spike, Wall Street analysts remain largely bullish on the name. So, what drove Axon's sell-off, and are the worries about this company justified? Axon's Sky-High P/E, SaaS Fears Came Home to Roost Axon's forward price-to-earnings (P/E) ratio, which peaked near 130x in August, certainly contributed to the decline. But the broader 2026 "SaaSpocalypse" accelerated the selling. Before the earnings release, Axon shares were down more than 20% in 2026. Many of the stock's biggest single-day drops coincided with heavy losses across the software sector, suggesting AI-disruption fears were pulling Axon down alongside other software names. That simultaneous sell-off looks somewhat indiscriminate. Investors seemed to be treating software-related companies as a single group, rather than differentiating cases where AI poses a real threat and those where it does not. Why Axon's Hardware-to-Software Flywheel Insulates It From AI Axon benefits from a simple reality: law enforcement depends on physical intervention. AI cannot physically restrain or arrest someone, which limits AI-disruption risk among Axon's primary customers — police and public-safety agencies. Yes, Axon has a significant software business that could, in theory, face AI-driven competitive pressure. But hardware remains central to its strategy. Consider the product that made Axon relevant in the first place: tasers. These are physical devices Axon has refined for more than three decades — not something an AI model can replicate overnight. Tasers are still a meaningful and growing revenue stream. Sales of tasers rose 32% in Q4 2025, and the category accounted for about one-third of Axon's full-year revenue, leaving a substantial portion of the business relatively insulated from AI disruption. Crucially, Axon's software is tightly integrated with its hardware. Body cameras capture video that feeds into Axon's digital evidence management platform, which in turn generates subscription revenue. Many of Axon's software tools rely on the data those devices produce. For example, Draft One uses body-cam audio to generate initial drafts of officers' incident reports, saving time and letting officers focus on policing and investigations rather than paperwork. To displace Axon's software, a competitor would typically need to supplant its body-camera ecosystem as well. Replacing an agency's established hardware and evidence-management systems would require extensive retraining and expose agencies to risk if evidence handling changes. Axon's long-standing relationships and trust with customers create a high barrier for newcomers. As Axon collects more device-generated data, its software offerings should improve, too. That accumulation of real-world evidence gives Axon a head start over potential competitors. Analysts Still See Large Upside After the Big Beats Axon's recent results underline the business strength. The company beat expectations on revenue and adjusted earnings per share (EPS), with revenue up 39%. Future contracted bookings — the value of signed contracts yet to be fulfilled — rose 43% to $14.4 billion. While not guaranteed revenue, that backlog is large relative to the $2.8 billion in total revenue Axon reported for 2025. Axon also reported a strong net revenue retention rate of 125%, meaning existing customers increased their spending by 25% year over year — a sign that Axon's products are delivering growing value. By 2028, Axon is targeting revenue of $6 billion, which implies roughly 29% annual growth through 2028. The company also aims to expand its adjusted EBITDA margin by 250 basis points to about 28%. The MarketBeat consensus price target for Axon once sat near $763, implying more than 45% upside. After the earnings release, analysts adjusted their targets lower; the updated average is near $654, still suggesting roughly 25% upside. Those downward revisions largely reflect analysts resetting targets after the stock's steep decline, not necessarily a negative reading of the company's results. Overall, Axon's outlook looks healthy, and the AI-disruption concerns that helped drive the sell-off appear overstated.
| 
No comments:
Post a Comment